Hongyi Hu
- Topics
- Cancer-related molecular mechanisms research (8 papers)MicroRNA in disease regulation (5 papers)Circular RNAs in diseases (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Hongyi Hu
27 papers receiving 428 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 206
- Cancer Research 132
- Oncology 64
- Pulmonary and Respiratory Medicine 52
- Epidemiology 50
Countries citing papers authored by Hongyi Hu
This map shows the geographic impact of Hongyi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyi Hu more than expected).
Fields of papers citing papers by Hongyi Hu
This network shows the impact of papers produced by Hongyi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyi Hu. The network helps show where Hongyi Hu may publish in the future.
Co-authorship network of co-authors of Hongyi Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Hongyi Hu. A scholar is included among the top collaborators of Hongyi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyi Hu. Hongyi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 12 | |
| 7 | 2 | |
| 8 | 18 | |
| 9 | 2 | |
| 10 | 16 | |
| 11 | 2 | |
| 12 | 23 | |
| 13 | 15 | |
| 14 | 57 | |
| 15 | Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway. | 23 |
| 16 | 54 | |
| 17 | 24 | |
| 18 | Intrathecal SRT1720, a SIRT1 agonist, exerts anti-hyperalgesic and anti-inflammatory effects on chronic constriction injury-induced neuropathic pain in rats. | 28 |
| 19 | 13 | |
| 20 | 59 |
About Hongyi Hu
Hongyi Hu is a scholar working on Otorhinolaryngology, Sensory Systems and Cancer Research, having authored 28 papers that have together received 430 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Otorhinolaryngology (39 citations), Cancer Research (132 citations) and Geriatrics and Gerontology (21 citations). Hongyi Hu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jia Liu, Zhen Xie, Weiqiang Yang, Yan Li, Ezra E.W. Cohen, Yaning Wang, Mark Kozloff, Everett E. Vokes, Theodore Karrison and Nicholas W. Choong. Their work appears in journals such as Oncogene, European Journal of Cancer and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.